Pinsent Masons advises NanoTemper in acquisition of SAW Instruments
12 Dec 2014 | 04:28 pm |
International law firm Pinsent Masons advised NanoTemper Technologies GmbH in its recent acquisition of SAW Instruments GmbH (Bonn, Germany).
By acquiring SAW Instruments and their proprietary Surface Acoustic Wave technology, NanoTemper expands its portfolio by an additional methodology for biomolecular interaction analysis.
The Pinsent Masons team was led by corporate partner, Tobias Rodehau, aligned by Dr. Florian Anselm, Legal Director, Olivia Irrgang and Marina Arntzen.
NanoTemper Technologies GmbH
NanoTemper Technologies, founded in 2008, is a globally operating high-tech company that develops, produces and markets instruments for biomolecular analytics. NanoTemper's proprietary technology MicroScale Thermophoresis (MST) allows identifying and developing drug candidates and enables customers to test the drugs' potency quickly and effectively.
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises Simpson Malt Limited on £90m refinancing deal
Multinational law firm Pinsent Masons has advised Simpson Malt Limited on a £90m asset based lending (ABL) facility with PNC Business Credit.
Pinsent Masons wins 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards
Pinsent Masons was named 'Construction Law Firm of the Year' and 'Energy and Resources Law Firm of the Year' at the Asian Legal Business Hong Kong Law Awards, which was held virtually on 27 November 2020.
Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises Bodymed AG on the sale to Nestlé Health Science
The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.
Pinsent Masons advises shareholders of Goodtill on its sale to SumUp
Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp
Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ
Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]